? Drug-resistant tuberculosis now threatens a large portion of the earth's population, and the development of new treatments for tuberculosis infection has become a national and international priority. Mycobacterium tuberculosis depends on a low molecular weight thiol, """"""""mycothiol,"""""""" to maintain a reducing intracellular environment and to remove exogenous electrophilic agents. Disruption of the enzymatic pathways of mycothiol biosynthesis and/or mycothiol-based detoxification could leave M. tuberculosis vulnerable to drugs, oxygen, and other stress factors, and constitutes a new tactic for the control of tuberculosis. The objective of this project is to develop inhibitors of the mycothiol-related enzymes of M. tuberculosis, and eventually to design new and successful treatments for tuberculosis. Three enzymes will be targeted initially: mycothione reductase, mycothiol S-conjugate amidase, and inosityl GIcNAc deacetylase, although others, including a cysteine ligase and a cysteine transacetylase, could be added. This work will be guided by enzymatic assays conducted by collaborators using existing screens, and by preliminary results that already indicate that substantial structural simplification in designing mycothiol analogues is possible. First, the minimum substrate requirements for the M. tuberculosis enzymes will be defined. Then, inhibitors based on these minimum structures will be synthesized and evaluated. New methods for the synthesis of mycothiol-analogous compounds will be developed, and new ideas for enzyme inhibitor design will be explored. The most active compounds will be taken as leads for further analogue development and for increasing the potency, specificity, bioavailability, and metabolic stability in M. tuberculosis itself. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI055760-02
Application #
6731185
Study Section
Special Emphasis Panel (ZAI1-AR-M (M1))
Program Officer
Sizemore, Christine F
Project Start
2003-04-15
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2006-03-31
Support Year
2
Fiscal Year
2004
Total Cost
$233,250
Indirect Cost
Name
Rutgers University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Won, Walter S; Knapp, Spencer (2013) ?-D-Arabinosyl 1-C-sulfonic acid. J Sulphur Chem 34:33-37
Ajayi, Kehinde; Thakur, Vinay V; Lapo, Robert C et al. (2010) Intramolecular alpha-glucosaminidation: synthesis of mycothiol. Org Lett 12:2630-3
Kim, Eun Ju; Love, Dona C; Darout, Etzer et al. (2010) OGA inhibition by GlcNAc-selenazoline. Bioorg Med Chem 18:7058-64
Knapp, Spencer; Fash, David; Abdo, Mohannad et al. (2009) GlcNAc-Thiazoline conformations. Bioorg Med Chem 17:1831-6
Amorelli, Benjamin; Yang, Chunhua; Rempel, Brian et al. (2008) N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines. Bioorg Med Chem Lett 18:2944-7
Kim, Eun J; Amorelli, Benjamin; Abdo, Mohannad et al. (2007) Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. J Am Chem Soc 129:14854-5
Knapp, Spencer; Ajayi, Kehinde (2007) The Anomeric Pudovik Rearrangement. Tetrahedron Lett 48:1945-1949
Knapp, Spencer; Abdo, Mohannad; Ajayi, Kehinde et al. (2007) Tautomeric modification of GlcNAc-thiazoline. Org Lett 9:2321-4
Knapp, Spencer; Darout, Etzer (2005) New reactions of selenocarboxylates. Org Lett 7:203-6